New England Asset Management Inc. boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,200 shares of the medical research company’s stock after buying an additional 600 shares during the period. New […]